These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 35422087)
1. SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells. Zhang Y; Liu Z; Wang X; Jian H; Xiao H; Wen T Cancer Gene Ther; 2022 Oct; 29(10):1514-1527. PubMed ID: 35422087 [TBL] [Abstract][Full Text] [Related]
2. Serine catabolism regulates mitochondrial redox control during hypoxia. Ye J; Fan J; Venneti S; Wan YW; Pawel BR; Zhang J; Finley LW; Lu C; Lindsten T; Cross JR; Qing G; Liu Z; Simon MC; Rabinowitz JD; Thompson CB Cancer Discov; 2014 Dec; 4(12):1406-17. PubMed ID: 25186948 [TBL] [Abstract][Full Text] [Related]
3. Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming. Liu Z; Fan M; Hou J; Pan S; Xu Y; Zhang H; Liu C; Hao X; Li X; Wang H Cell Death Dis; 2023 Feb; 14(2):144. PubMed ID: 36806313 [TBL] [Abstract][Full Text] [Related]
4. ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaption. Li X; Zhang K; Hu Y; Luo N Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894856 [TBL] [Abstract][Full Text] [Related]
5. Serine hydroxymethyltransferase 2: a novel target for human cancer therapy. Xie M; Pei DS Invest New Drugs; 2021 Dec; 39(6):1671-1681. PubMed ID: 34215932 [TBL] [Abstract][Full Text] [Related]
6. Cellular Pharmacodynamics of a Novel Pyrrolo[3,2- Dekhne AS; Ning C; Nayeen MJ; Shah K; Kalpage H; Frühauf J; Wallace-Povirk A; O'Connor C; Hou Z; Kim S; Hüttemann M; Gangjee A; Matherly LH Mol Pharmacol; 2020 Jan; 97(1):9-22. PubMed ID: 31707355 [TBL] [Abstract][Full Text] [Related]
7. Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs. Minton DR; Nam M; McLaughlin DJ; Shin J; Bayraktar EC; Alvarez SW; Sviderskiy VO; Papagiannakopoulos T; Sabatini DM; Birsoy K; Possemato R Mol Cell; 2018 Feb; 69(4):610-621.e5. PubMed ID: 29452640 [TBL] [Abstract][Full Text] [Related]
8. Cancer proteome and metabolite changes linked to SHMT2. Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271 [TBL] [Abstract][Full Text] [Related]
9. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT. Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250 [TBL] [Abstract][Full Text] [Related]
11. Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma. Clark RA; Qiao J; Jacobson JC; Chung DH Oncotarget; 2022; 13():32-45. PubMed ID: 35018218 [TBL] [Abstract][Full Text] [Related]
12. Thymol inhibits bladder cancer cell proliferation via inducing cell cycle arrest and apoptosis. Li Y; Wen JM; Du CJ; Hu SM; Chen JX; Zhang SG; Zhang N; Gao F; Li SJ; Mao XW; Miyamoto H; Ding KF Biochem Biophys Res Commun; 2017 Sep; 491(2):530-536. PubMed ID: 28389245 [TBL] [Abstract][Full Text] [Related]
13. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation. Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469 [TBL] [Abstract][Full Text] [Related]
14. Role of Mitochondrial and Cytosolic Folylpolyglutamate Synthetase in One-Carbon Metabolism and Antitumor Efficacy of Mitochondrial-Targeted Antifolates. O'Connor C; Schneider M; Katinas JM; Nayeen MJ; Shah K; Magdum T; Sharma A; Kim S; Bao X; Li J; Dann CE; Gangjee A; Matherly LH; Hou Z Mol Pharmacol; 2024 Sep; 106(4):173-187. PubMed ID: 39048308 [TBL] [Abstract][Full Text] [Related]
15. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Wilke AC; Doebele C; Zindel A; Lee KS; Rieke SA; Ceribelli M; Comoglio F; Phelan JD; Wang JQ; Pikman Y; Jahn D; Häupl B; Schneider C; Scheich S; Tosto FA; Bohnenberger H; Stauder P; Schnütgen F; Slabicki M; Coulibaly ZA; Wolf S; Bojarczuk K; Chapuy B; Brandts CH; Stroebel P; Lewis CA; Engelke M; Xu X; Kim H; Dang TH; Schmitz R; Hodson DJ; Stegmaier K; Urlaub H; Serve H; Schmitt CA; Kreuz F; Knittel G; Rabinowitz JD; Reinhardt HC; Vander Heiden MG; Thomas C; Staudt LM; Zenz T; Oellerich T Blood; 2022 Jan; 139(4):538-553. PubMed ID: 34624079 [TBL] [Abstract][Full Text] [Related]
16. The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. Parsa S; Ortega-Molina A; Ying HY; Jiang M; Teater M; Wang J; Zhao C; Reznik E; Pasion JP; Kuo D; Mohan P; Wang S; Camarillo JM; Thomas PM; Jain N; Garcia-Bermudez J; Cho BK; Tam W; Kelleher NL; Socci N; Dogan A; De Stanchina E; Ciriello G; Green MR; Li S; Birsoy K; Melnick AM; Wendel HG Nat Cancer; 2020; 1():653-664. PubMed ID: 33569544 [TBL] [Abstract][Full Text] [Related]
17. The role of SHMT2 in modulating lipid metabolism in hepatocytes via glycine-mediated mTOR activation. Choi YJ; Lee G; Yun SH; Lee W; Yu J; Kim SK; Lee BH Amino Acids; 2022 May; 54(5):823-834. PubMed ID: 35212811 [TBL] [Abstract][Full Text] [Related]
18. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production. Kim WS; Lee KS; Kim JH; Kim CK; Lee G; Choe J; Won MH; Kim TH; Jeoung D; Lee H; Kim JY; Ae Jeong M; Ha KS; Kwon YG; Kim YM Free Radic Biol Med; 2017 Nov; 112():567-577. PubMed ID: 28888620 [TBL] [Abstract][Full Text] [Related]
19. Scoulerine promotes cell viability reduction and apoptosis by activating ROS-dependent endoplasmic reticulum stress in colorectal cancer cells. Tian J; Mo J; Xu L; Zhang R; Qiao Y; Liu B; Jiang L; Ma S; Shi G Chem Biol Interact; 2020 Aug; 327():109184. PubMed ID: 32590070 [TBL] [Abstract][Full Text] [Related]
20. Multiomics analysis reveals serine catabolism as a potential therapeutic target for MELAS. Liufu T; Zhao X; Yu M; Xie Z; Meng L; Lv H; Zhang W; Yuan Y; Xing G; Deng J; Wang Z FASEB J; 2024 Jun; 38(12):e23742. PubMed ID: 38865203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]